Published in Cell on December 27, 1996
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30
Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol (2002) 5.20
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol (2007) 4.64
Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol (2003) 4.47
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog (2009) 4.24
Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol (2007) 3.93
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol (1998) 3.84
The structural biology of HIV assembly. Curr Opin Struct Biol (2008) 3.71
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A (1998) 3.24
TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol (2010) 3.21
Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol (2004) 3.09
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol (1998) 3.06
Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol (2003) 2.73
Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J Virol (1999) 2.66
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J (2001) 2.64
Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol (2005) 2.54
Retroviral restriction factor TRIM5alpha is a trimer. J Virol (2005) 2.52
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol (2004) 2.51
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol (1998) 2.49
Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.41
Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad Sci U S A (2010) 2.40
Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.37
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J (1999) 2.33
Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell (2009) 2.32
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol (2006) 2.31
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol (2008) 2.30
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A (2008) 2.23
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J Virol (2008) 2.22
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci U S A (2005) 2.21
Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc Natl Acad Sci U S A (2002) 2.19
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J Virol (2001) 2.17
HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog (2010) 2.12
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol (1999) 2.08
Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J Virol (2000) 2.07
Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci (2002) 1.97
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J Virol (2002) 1.96
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog (2009) 1.94
Early steps of retrovirus replicative cycle. Retrovirology (2004) 1.94
Characterization of Rous sarcoma virus Gag particles assembled in vitro. J Virol (2001) 1.85
An intracellular block to primate lentivirus replication. Proc Natl Acad Sci U S A (2002) 1.81
Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells. J Virol (2005) 1.79
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J Virol (2006) 1.77
Visualization of a missing link in retrovirus capsid assembly. Nature (2009) 1.75
Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology (2007) 1.75
Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J Virol (1998) 1.73
Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci U S A (2002) 1.71
Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol (2005) 1.71
In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). J Virol (2006) 1.70
Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci U S A (1997) 1.68
Genetic determinants of Rous sarcoma virus particle size. J Virol (1998) 1.67
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol (2006) 1.65
Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology (2006) 1.63
Conformation of the HIV-1 Gag protein in solution. J Mol Biol (2006) 1.59
Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J (2003) 1.58
Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions. J Virol (2001) 1.55
Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J Virol (2002) 1.55
Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat Struct Mol Biol (2009) 1.53
Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J Virol (2009) 1.53
The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. J Virol (2012) 1.52
The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol (2012) 1.50
A cyclophilin functions in pre-mRNA splicing. EMBO J (2002) 1.49
Solid-state NMR studies of HIV-1 capsid protein assemblies. J Am Chem Soc (2010) 1.49
Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother (2008) 1.46
The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology (2007) 1.43
Nuclear landscape of HIV-1 infection and integration. Nat Rev Microbiol (2016) 1.41
Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J Virol (2000) 1.40
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis. Nature (2016) 1.39
Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci (1997) 1.36
Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog (2013) 1.36
Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog (2013) 1.35
Retroviral capsid determinants of Fv1 NB and NR tropism. J Virol (2004) 1.35
Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. J Virol (2006) 1.35
Role of Vif in stability of the human immunodeficiency virus type 1 core. J Virol (2000) 1.34
Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations. J Virol (2006) 1.33
HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes. Biophys J (2001) 1.32
Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells. J Virol (2008) 1.30
Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J Virol (1998) 1.29
Flexibility in HIV-1 assembly subunits: solution structure of the monomeric C-terminal domain of the capsid protein. Biophys J (2007) 1.29
Motions on the millisecond time scale and multiple conformations of HIV-1 capsid protein: implications for structural polymorphism of CA assemblies. J Am Chem Soc (2012) 1.28
A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J Virol (2007) 1.28
Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J Virol (1997) 1.25
Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog (2011) 1.24
Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase. J Virol (2003) 1.24
Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J Virol (2005) 1.24
Enzymes: An integrated view of structure, dynamics and function. Microb Cell Fact (2006) 1.21
Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag. J Virol (2005) 1.21
RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. J Virol (2010) 1.18
The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release. J Virol (2004) 1.18
On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J Virol (2011) 1.17
Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity. Virology (1998) 1.17
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. J Virol (2012) 1.17
Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice. Proc Natl Acad Sci U S A (2014) 1.16
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
Assembly and analysis of conical models for the HIV-1 core. Science (1999) 6.35
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science (1997) 6.10
Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature (2000) 5.60
Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science (1996) 5.44
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A (1996) 4.83
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol (1994) 3.56
Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol (1997) 3.50
Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res (1998) 3.11
Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04
Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J (1999) 2.79
Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr D Biol Crystallogr (1999) 2.77
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2009) 2.68
Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem (1998) 2.44
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J (1997) 2.29
Chemical and enzymatic biotin-labeling of oligodeoxyribonucleotides. Nucleic Acids Res (1985) 2.29
Penicillin acylase has a single-amino-acid catalytic centre. Nature (1995) 2.18
Structure of the C-terminal domain of FliG, a component of the rotor in the bacterial flagellar motor. Nature (1999) 1.76
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Identification of an activation region in the proteasome activator REGalpha. Proc Natl Acad Sci U S A (1998) 1.54
Ku proteins join DNA fragments as shown by atomic force microscopy. Cancer Res (1997) 1.51
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J Biol Chem (1997) 1.47
On the theory of speciation induced by transposable elements. Genetics (1984) 1.40
Molecular basis for Rac1 recognition by guanine nucleotide exchange factors. Nat Struct Biol (2001) 1.39
Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci (1997) 1.36
The publication rates of presentations at major Spine Specialty Society meetings (NASS, SRS, ISSLS). Spine (Phila Pa 1976) (1999) 1.34
Structure of a new crystal form of tetraubiquitin. Acta Crystallogr D Biol Crystallogr (2001) 1.28
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein Sci (1996) 1.26
Pseudomonas cepacia 2,2-dialkylglycine decarboxylase. Sequence and expression in Escherichia coli of structural and repressor genes. J Biol Chem (1990) 1.26
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol (2010) 1.23
Homologous and illegitimate recombination in developing Xenopus oocytes and eggs. Mol Cell Biol (1993) 1.23
Crystal structure of human uroporphyrinogen III synthase. EMBO J (2001) 1.23
Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. J Mol Biol (1996) 1.16
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag). J Virol (2001) 1.14
Connexins in the sinoatrial and atrioventricular nodes. Adv Cardiol (2006) 1.14
17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol (2012) 1.11
Multiple-copy genes: production and modification of monomeric peptides from large multimeric fusion proteins. Gene (1985) 1.10
Evidence for a quantum phase transition in Pr2-xCe(x)CuO4-delta from transport measurements. Phys Rev Lett (2004) 1.09
Nanoscale hydrophobic interaction and nanobubble nucleation. Phys Rev Lett (2004) 1.06
Crystal structure of the Saccharomyces cerevisiae ubiquitin-conjugating enzyme Rad6 at 2.6 A resolution. J Biol Chem (1998) 1.06
Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex. Biochemistry (1997) 1.05
Differential transcription of baculovirus late and very late promoters: fractionation of nuclear extracts by phosphocellulose chromatography. J Virol (1995) 1.04
Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Cancer Res (1991) 1.03
Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci (1997) 1.02
Inhibition of Mycoplasma pneumoniae by actinomycin D. Antimicrob Agents Chemother (1973) 1.01
Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment. Phys Med Biol (2009) 0.99
Protective factors and young adolescent tendency to abstain from alcohol use: a model using two waves of intervention study data. Am J Community Psychol (1996) 0.99
EphA/ephrin-A signaling is critically involved in region-specific apoptosis during early brain development. Cell Death Differ (2012) 0.99
Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibody. Clin Pharmacol Ther (2013) 0.97
Letter: Acetyl transfer reaction in catechol acetate malonate. A model for the biosynthesis of polyketides and fatty acids. J Am Chem Soc (1975) 0.96
Axolemmal repair requires proteins that mediate synaptic vesicle fusion. J Neurobiol (2000) 0.96
Expression, purification and crystallization of penicillin G acylase from Escherichia coli ATCC 11105. Protein Eng (1990) 0.95
Selective 2'-benzoylation at the cis 2',3'-diols of protected ribonucleosides. New solid phase synthesis of RNA and DNA-RNA mixtures. Nucleic Acids Res (1982) 0.94
Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani. EMBO J (1999) 0.93
Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase. Blood (2001) 0.91
Diffuse lamellar keratitis: incidence, associations, outcomes, and a new classification system. J Cataract Refract Surg (2001) 0.91
Large-scale molecular-dynamics simulation of nanoscale hydrophobic interaction and nanobubble formation. J Chem Phys (2005) 0.90
Plasmalemmal repair of severed neurites of PC12 cells requires Ca(2+) and synaptotagmin. J Neurosci Res (2000) 0.90
Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors. Pediatr Surg Int (1997) 0.88
Heat shock transcription factor 1 binds selectively in vitro to Ku protein and the catalytic subunit of the DNA-dependent protein kinase. J Biol Chem (1997) 0.87
Defining polyubiquitin chain topology. Nat Struct Biol (2001) 0.86
Structural diversity in metal ion chelation and the structure of uroporphyrinogen III synthase. Biochem Soc Trans (2002) 0.84
Characteristics of sensitometric curves of radiographic films. Med Phys (2003) 0.83
The melting lines of model silicon calculated from coexisting solid-liquid phases. J Chem Phys (2004) 0.83
The proteasome 11S regulator subunit REG alpha (PA28 alpha) is a heptamer. Protein Sci (1997) 0.83
Analysis of image quality for real-time target tracking using simultaneous kV-MV imaging. Med Phys (2008) 0.83
Antioxidant effect of ethyl pyruvate in respiring neonatal cerebrocortical slices after H(2)O(2) stress. Neurochem Int (2008) 0.83
Assessment of cervical ligamentous injury in trauma patients using MRI. J Spinal Disord (2001) 0.83
Melting temperature of ice Ih calculated from coexisting solid-liquid phases. J Chem Phys (2005) 0.82
cGMP facilitates calcium current via cGMP-dependent protein kinase in isolated rabbit ventricular myocytes. Pflugers Arch (1998) 0.82
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib. Br J Ophthalmol (2008) 0.82
Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies. Biochemistry (1986) 0.81
Laser modulation of heat and capsaicin receptor TRPV1 leads to thermal antinociception. J Dent Res (2010) 0.81
A model of the effects of protective parent and peer factors on young adolescent alcohol refusal skills. J Prim Prev (1996) 0.81
Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation. Br J Pharmacol (2012) 0.79
Antiangiogenic effect of KR31372 in rat sponge implant model. J Pharmacol Exp Ther (2001) 0.79
Multi-species prostate implant treatment plans incorporating 192Ir and 125I using a Greedy Heuristic based 3D optimization algorithm. Med Phys (2007) 0.78
Structures of wild-type chloromet and L103N hydroxomet Themiste zostericola myohemerythrins at 1.8 A resolution. Biochemistry (1997) 0.78
Exogenous peptide and protein expression levels using retroviral vectors in human cells. Mol Ther (2001) 0.77
Complex of ribonuclease from Streptomyces aureofaciens with 2'-GMP at 1.7 A resolution. Acta Crystallogr D Biol Crystallogr (1993) 0.77
Subretinal aspiration biopsy of ocular lymphoma. Am J Ophthalmol (1997) 0.76
Tattle tales. Nat Struct Biol (1996) 0.76
Effect of amino acids on isolated colonic smooth muscle from the rabbit. J Pharmacol Exp Ther (1985) 0.76
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases. Cell Mol Biol (Noisy-le-grand) (2009) 0.75
Record power, ultra-broadband supercontinuum source based on highly GeO<sub>2</sub> doped silica fiber. Opt Express (2016) 0.75